Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Most patients tolerate treatment very well, but some may experience nausea, constipation, bloating, or fatigue during the first few weeks
A study in the New England Journal of Medicine highlighted that participants using a GLP-1 experienced weight loss that included both fat and lean mass
New numbness, wrist pain, or worsening sleep apnea symptoms should be discussed with a clinician
Coverage for weight loss is a different story: only 13 states cover obesity-indicated GLP-1s as of January 2026, and that number has been shrinking as states face budget pressure
RAA: rapid-acting insulin analogue
US$ 21.99
US$ 29.05
US$ 22.24
US$ 22.77
